Are you in compliance?

Don't miss out! Sign up today for our weekly newsletters and stay abreast of important GRC-related information and news.

Get updates on Compliance Week offerings, including new features, databases, research, and other resources, along with announcements of upcoming Webcasts, conferences, seminars, CPE/CLE opportunities and more.

Published every Thursday, Compliance Week Europe offers a condensed summary of risk, audit, and compliance news either originating in Europe, or of special interest to European compliance professionals. This newsletter will follow developments by the European Commission, as well as those of national governments across the region, or any U.S.-based news that might have consequence across the Atlantic. Frequency: weekly; Thursday a.m.

A fresh edition of Compliance Week delivered via e-mail and online every Tuesday morning, relentlessly focused on the disclosure, reporting and compliance requirements of our 25,000+ paying subscribers.

Published every Friday, Compliance Weekend was launched at the behest of subscribers, and offers a quick Plain English review of the week's key developments. We hope you enjoy this supplement to Compliance Week's Tuesday edition.

Stanford May No Longer Be Addicted to Anti-Anxiety Drugs, But Now He Says He Has Amnesia

Bruce Carton | November 11, 2011

Back in January 2011, U.S. District Judge David Hittner postponed Allen Stanford's criminal trial after psychiatrists testified that Stanford was not capable of helping with his defense. A big part of the problem, the psychiatrists said, was that despite being in federal custody, Stanford somehow managed to become addicted to an anti-anxiety drug called Klonopin that had left him "mentally foggy." Judge Hittner ruled that Stanford had to be weaned off of the drug and deemed competent before standing trial.

Ten months later, it appears that Stanford has finally completed his drug rehabilitation treatment. Reuters reported yesterday that Stanford has left the medical center at the Butner Federal Correctional Complex in North Carolina, where he has been undergoing treatment since January. Stanford is now in custody at a transfer facility in Oklahoma City.

CNBC reports that Stanford's trial is currently scheduled for January 2012, but it is unclear if that date will stick. And in case the judge deems Stanford to have sufficiently weaned himself off of the Klonopin, Stanford says he has a new ailment that will further delay the case. According to Ed Snyder, an attorney representing many Stanford investors trying to get their money back, "Allen Stanford says he has amnesia.  He can't remember anything about his past and what he did for 20 years there in Antigua."